Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]

Pembrolizumab shows improvement in overall survival for clear cell renal cell...

Prof Jens Bedke - Klinikum Stuttgart-Katharinenhospital, Stuttgart, Germany

Pembrolizumab shows improvement in overall survival for clear cell renal cell carcinoma ( Prof Jens Bedke - Klinikum Stuttgart-Katharinenhospital, Stuttgart, Germany )

Blinatumomab added to chemotherapy improves disease-free survival in newly...

Dr Rachel Rau - University of Washington, Seattle, USA

Blinatumomab added to chemotherapy improves disease-free survival in newly diagnosed NCI standard risk paediatric B-ALL ( Dr Rachel Rau - University of Washington, Seattle, USA )

Outcomes and survival in newly diagnosed, older, AML patients from the Beat AML...

Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA

Outcomes and survival in newly diagnosed, older, AML patients from the Beat AML master trial in the venetoclax/azacitidine age ( Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA )

IDH2 mutation associated with favourable outcome in older adults with newly...

Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA

IDH2 mutation associated with favourable outcome in older adults with newly diagnosed ALL treated with lower-intensity therapy ( Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA )

Demographics, characteristics, survival and outcomes in older, untreated, AML...

Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA

Demographics, characteristics, survival and outcomes in older, untreated, AML with NPM1 mutations or KMT2A rearrangements ( Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA )

Beat AML master trial update: A clinical trial for acute myeloid leukaemia

Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA

Beat AML master trial update: A clinical trial for acute myeloid leukaemia ( Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA )

Impact of MRD on progression-free survival in MM patients treated with...

Dr Elias Mai - University Hospital Heidelberg, Heidelberg, Germany

Impact of MRD on progression-free survival in MM patients treated with isatuximab, lenalidomide, bortezomib and dexamethasone ( Dr Elias Mai - University Hospital Heidelberg, Heidelberg, Germany )

Study shows association between tumour KIM-1 gene (HAVCR1) expression and...

Dr Panagiotis Vlachostergios - IASO Thessalias General Hospital, Larissa, Greece

Study shows association between tumour KIM-1 gene (HAVCR1) expression and immune infiltrates in RCC ( Dr Panagiotis Vlachostergios - IASO Thessalias General Hospital, Larissa, Greece )

Guiding metastasis-directed therapy with different PET/CT radiotracers affects...

Dr Francesco Lanfranchi - University of Genoa, Genoa, Italy

Guiding metastasis-directed therapy with different PET/CT radiotracers affects distant disease control in HSPC patients ( Dr Francesco Lanfranchi - University of Genoa, Genoa, Italy )

Breast conserving surgery and IORT can manage locally recurrent breast cancer

Dr Fabiana Gregucci - Weill Cornell Medicine, New York, USA

Breast conserving surgery and IORT can manage locally recurrent breast cancer ( Dr Fabiana Gregucci - Weill Cornell Medicine, New York, USA )

Overview of cancer health disparities: Current state and future directions

Dr Ophira Ginsburg - National Cancer Institute, Bethesda, USA

Overview of cancer health disparities: Current state and future directions ( Dr Ophira Ginsburg - National Cancer Institute, Bethesda, USA )

Addressing Breast Cancer Disparities in Africa

Dr Paul Chilwesa - Population Health & Health Systems Strengthening Roche...

Addressing Breast Cancer Disparities in Africa ( Dr Paul Chilwesa - Population Health & Health Systems Strengthening Roche, Basel, Switzerland )

More from ecancer